Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS

Neurofilaments are leading neurochemical biomarkers for amyotrophic lateral sclerosis (ALS). Here, we investigated the effect of preanalytical factors on neurofilament concentrations in cerebrospinal fluid (CSF) in a "reverse" round-robin with 15 centers across Europe/U.S.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2016-07, Vol.17 (5-6), p.404-413
Hauptverfasser: Oeckl, Patrick, Jardel, Claude, Salachas, François, Lamari, Foudil, Andersen, Peter M, Bowser, Robert, de Carvalho, Mamede, Costa, Júlia, Van Damme, Philip, Gray, Elizabeth, Grosskreutz, Julian, Hernández-Barral, María, Herukka, Sanna-Kaisa, Huss, André, Jeromin, Andreas, Kirby, Janine, Kuzma-Kozakiewicz, Magdalena, Amador, Maria Del Mar, Mora, Jesús S, Morelli, Claudia, Muckova, Petra, Petri, Susanne, Poesen, Koen, Rhode, Heidrun, Rikardsson, Anna-Karin, Robberecht, Wim, Rodríguez Mahillo, Ana I, Shaw, Pamela, Silani, Vincenzo, Steinacker, Petra, Turner, Martin R, Tüzün, Erdem, Yetimler, Berrak, Ludolph, Albert C, Otto, Markus
Format: Artikel
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Neurofilaments are leading neurochemical biomarkers for amyotrophic lateral sclerosis (ALS). Here, we investigated the effect of preanalytical factors on neurofilament concentrations in cerebrospinal fluid (CSF) in a "reverse" round-robin with 15 centers across Europe/U.S.
ISSN:2167-8421